ITC Issues Ban on Infringing Photodynamic Therapy Imports
Published Date: 5/11/2026
Notice
Summary
The U.S. International Trade Commission found that some photodynamic therapy devices and related products imported by certain companies broke patent rules. To fix this, they’re blocking these products from entering the U.S. without permission and ordering the companies to stop selling them. This means affected businesses must act fast or face legal and financial consequences.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Limited Exclusion Order blocking imports
The Commission issued a Limited Exclusion Order (LEO) prohibiting the unlicensed entry into the United States of infringing photodynamic therapy systems, components, and pharmaceutical products that are manufactured by or on behalf of the named respondents or their affiliates. The determination was made by Commission vote on May 6, 2026 and applies to products found to infringe the asserted patents.
Cease-and-desist orders for named respondents
The Commission issued cease-and-desist orders (CDOs) against each named respondent — Biofrontera Inc.; Biofrontera Pharma GmbH; Biofrontera Bioscience GmbH; and Biofrontera AG — requiring them to stop selling the infringing photodynamic therapy systems, components, and related pharmaceutical products. The Commission terminated the investigation after issuing these orders following its May 6, 2026 vote.
Zero percent bond during Presidential review
The Commission set a bond of zero percent (0%) for any importations of the infringing products during the period of Presidential review, under 19 U.S.C. 1337(j). This means importers would not have to post a monetary bond for the covered products during that review period.
Orders suspended for '028 patent pending appeals
The Commission suspended the remedial orders as to U.S. Patent No. 11,697,028 (the '028 patent) in light of a Final Written Decision (FWD) from the Patent Trial and Appeal Board and pending any further action before the Board or potential appeals. The suspension applies while the Board and any appeals remain active.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13416 — Magnesia Carbon Bricks From China and Mexico; Institution of Five-Year Reviews
The U.S. is checking if special taxes on magnesia carbon bricks from China and Mexico should stay or go. This review affects importers, manufacturers, and anyone involved in these bricks, with a deadline to share info by July 31, 2026. The results could impact prices and trade rules, so keep an eye out!
2026-13415 — Seamless Refined Copper Pipe and Tube From Vietnam; Institution of a Five-Year Review
The U.S. is checking if it should keep extra taxes on seamless refined copper pipes and tubes from Vietnam. This review started July 1, 2026, and affects businesses that make or sell these pipes in the U.S. If the taxes go away, it might hurt American companies, so the government wants to hear from everyone by July 31, 2026.
2026-13436 — Polyvinyl Alcohol From China and Japan; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its review to decide if special taxes on polyvinyl alcohol from China and Japan should continue. This affects companies that make or sell this material in the U.S. The review started on June 5, 2026, and could impact prices and trade rules soon.
2026-13411 — Metal Lockers From China; Institution of Five-Year Reviews
The U.S. is checking if metal lockers from China still need special import taxes to protect American makers. If these taxes are removed, it could hurt local businesses. Companies and folks interested have until July 31, 2026, to share their thoughts, so the government can decide what’s best.
2026-13417 — Ironing Tables From China; Institution of a Five-Year Review
The U.S. is reviewing whether to keep tariffs on ironing tables from China to protect American makers from unfair pricing. If the tariffs are removed, it could hurt U.S. businesses that make these tables. People and companies have until July 31, 2026, to share their thoughts before a final decision is made.
2026-13435 — Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Notice of Institution of Investigation
The U.S. International Trade Commission is starting an investigation because Seer, Inc. and Brigham and Women's Hospital say some imported protein research tools are breaking their patents. This could lead to stopping those products from being sold in the U.S., affecting companies that make or sell these tools. The investigation kicks off now and could impact the market and money flow in this field soon.
Previous / Next Documents
Previous: 2026-09242 — Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm)
The FDA just gave Denali Therapeutics a special priority review voucher for their rare pediatric disease drug AVLAYAH, approved in March 2026. This voucher speeds up the review of future medicines, helping kids with rare diseases get treatments faster. It’s a big win for patients, the company, and anyone watching rare disease drug development!
Next: 2026-09244 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products
The FDA is asking for public comments on their plan to keep testing how they communicate about medical devices and radiation products. This helps them make sure their messages reach patients, caregivers, and healthcare pros clearly and effectively. Comments are due by June 10, 2026, and this review won’t cost anyone extra but will improve important health info.